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Thymidylate synthase expression and activity: relation
to S-phase parameters and 5-fluorouracil sensitivity
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Summary Six human cancer cell lines exhibiting a large range of sensitivity to 5-fluorouracil (5-FU) were evaluated forthymidylate synthase
(TS) and p53 gene expression, TS and dihydropyrimidine dehydrogenase (DPD) activity, as well as cell cycle parameters, S-phase fraction
(SPF), bromodeoxyuridine labelling index (LI) and S-phase duration (SPD). All these parameters were investigated for 7 days in
asynchronously growing cell populations and compared with the cell sensifivity to 5-FU. No significant correlation was found between
S-phase parameters and TS gene expression and/or actvity. TS actvity was higher in proliferating cells; however, it was not significantly
higher in rapidly growing cell lines with short SPD. NeitherTS gene expression noractvity was found to correlate with 5-FU sensitivity. On the
another hand, a statistically significant correlation (P < 0.0001) was observed between LI and SPD and 5-FU sensitivity. The present results
suggest that cell cycle parameters such as SPD and/or LI could be better parameters for 5-FU sensifivity predicon than TS gene expression
and/or activity. This could be especially informative in cases of concomitant radio-chemotherapy as S-phase parameters are already
proposed for hyperfractionated radiotherapy planning.
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Thymidylate synthase (TS) catalyses the reductive methylation
of deoxyuridine monophosphate (dUMP) to deoxythymidine
monophosphate (dTMP) using 5.10-methylene-tetrahydrofolate
(5.10-CH,FH4) as a methyl donor co-substrate. This reaction is an
essential step in DNA biosynthesis. as it provides the only de novo
source of dTMP. Another way is the thymidine salvage pathway.
which can produce dTMP from thymidine by thymidine kinase
(TK) action. TS is a critical target for fluoropyrimidine drugs
widely used in cancer treatment. either alone or as radiation
sensitizers. The metabolization of 5-fluorouracil (5-FU) in cancer
cells results in 5-fluorodeoxyuridine monophosphate (FdUMP)
synthesis. w%hich inhibits DNA synthesis by TS blocking through a
tight covalent ternary complex with TS. 5,1O-CH,FH4 and FdUMP.
Other 5-FU metabolites are incorporated into DNA and RNA.
Different mechanisms of 5-FU resistance have been described.
Althougrh each ofthese mechanisms has been documented in both
in vitro and in viv-o model systems. their relative contribution to
the development of clinical drug resistance remains uncertain.
However, there is agrowing body ofevidence to suggest that resis-
tance to the cytotoxic effects of the fluoropyrimidines as mani-
fested in patient tumour specimens may be mediated via a
TS-directed process. Specifically. two mechanisms have been
identified that may have direct clinical relevance, and include a
relative deficiency in intracellular folates resulting in decreased
inhibition of TS activity and/or increased expression of TS.
Several mechanisms have been described that can account for
modification in the activity of TS. Previous studies have demon-
strated that TS activity is higher during DNA replication and
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decreases when cells are non-dividing (Storms et al. 1984) and is
associated with proliferation (Pestalozzi et al, 1995). However.
molecular events and cell cycle events that influence or control TS
activity and TS gene expression are poorly understood. Even ifTS
activity can be associated with proliferation. its regulation may be
independent of DNA synthesis and cell cycle phase (Jenh et al.
1985). Recently. Pestalozzi et al (1995) showed that TS protein
levels are directly associated with S-phase in asynchronously
growinc neoplastic cells. but. surprisingly. no increase in TS
expression was detected in the S-phase population of asvnchro-
nous cells.
The first purpose of this study was to analyse TS gene expres-
sion and enzyme activity in relation to the S-phase fraction in six
human cancer cell lines growing asynchronously according to
their respective sensitivity to 5-FU. Moreover. as we previously
demonstrated that cell lines with a shorter doubling time exhibited
significantly higher sensitivity to 5-FU (Mirjolet et al. 1997). cell
cycle kinetic parameters (labelling index and S-phase duration)
were evaluated using flow cytometry. The investigated cell lines
were representative ofsquamous cell carcinoma ofthe upper aero-
digestive tract treated by concomitant radio-chemotherapy and
also corresponded to the spectrum of human malignancies treated
by 5-FU. i.e. digestive tract. breast. and head and neck cancers.
None of the cell lines had previously been exposed to 5-FU. and
thus exhibited spontaneous difference in sensitivity to 5-FU.
MtATERIALS AND METHODS
Materials and chemicals
Cell culture materials were purchased from Costar (Dutscher.
Brumath. France). culture media and additives from Life
Technologies (Gibco. Cergy-Pontoise. France). except for fetal
calf serum. which was obtained from Costar. 5-FU from Sigma
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(Saint-Quentin Fallavier, France), [5-3HJdUMP from Amnersham
(Les Ulis, France) with a specific activity of 0.37 MBq ml-'.
Racemic dl,tetrahydrofolic acid from Schircks Laboratories
(Jona, Switzerland). Ready safe scintillation cocktail and scintilla-
tion vials were from Beckman (Gagny, France). Taq-polymerase
was obtained from Eurobio (Les Ulis, France). RNAase H, random
primers, SuperScript II DNA polymerase were purchased from
Life Technologies. Deoxynucleotide triphosphate was purchased
from Pharmacia Biotech (Orsay, France). Anti-bromodeoxy-
uridine monoclonal antibodies were provided by Dako (Trappes,
France). All otherchemicals were purchased from Sigma and were
ofmolecular biology grade.
Cell culture
CAL51 human breast adenocarcinoma, PANC3 pancreas carci-
noma, CAL27 and CAL33 human head and neck carcinoma cell
lines were kindly provided by Dr JL Fischel (Centre Antoine
Lacassagne, Nice, France), FaDu and KB, head and neck carci-
noma cell lines, were obtained from Professor A Hanauske
(Munich University, Germany) as part of the EORTC Preclinical
Therapeutic Models Group exchange programme. All cell lines
were grown in 75-cm plastic tissue culture flasks in RPMI-1640
medium supplemented with 10% heat inactivated fetal calf serum,
penicillin (100 i.u. ml-'), streptomycin (100gg ml-') in a 37°C, 5%
CO, atmosphere. Forall experiments performed ondays 3, 5 or 7 of
growth, cells were seeded on day 0 at adensity of 104cells ml-'.
Cytotoxicity assay
MTr assays were carried out according to a previously reported
procedure (Barberi Heyob et al, 1993). Briefly, cells were seeded
at an initial density of 2.lOW cells ml-' in 96-well microtitration
plates. Seventy-two hours after plating, cells were exposed for
72 h to 5-FU concentrations ranging from 0.08 to 4. 0 JIgM, each
concentration being tested in sextuplicate. An aliquot of 50 S of
0.5% MTT solution was then added to each well and incubated for
3 h at 37°C to allow MIT metabolization. The formazan crystals
were dissolved by adding 50 S per well of 25% sodium dodecyl
sulphate solution with vigorous pipetting. Absorbance was
measured at 540 nm using a Multiskan MCC/340 plate reader
(Labsystem, Cergy-Pontoise, France). Results were expressed as
relative absorbance to untreated controls. 5-FU concentrations
yielding 50% growth inhibition (ICy) were calculated using
medium-effect algorithm (Chou and Talalay, 1987) and expressed
as mean values ofthree independent experiments.
Doubling time
For proliferation assays, cells were seeded on day 0 at a density of
2 xlO cells cm-2. Doubling times were calculated from 120-h cell
growth plots using linear regression analysis.
TSactty
TS activity was measured according to the tritium-release assay
described by Beck et al (1994). Cell suspension (4.106 cells ml-')
in 50 mm Tris-HCl buffer, pH 7.4, containing 2 mM dithiodureitol
was sonicated (VMriis, Virsonic 60, Fisher Scientific OSI,
Elancourt, France) on ice (15 s, 23 kHz). Cell extracts weremime-
diately centrifuged at 100 000 g for 30 min (40C). Cytosols were
incubated with [3H]dUMP (100 nm final concentration) and 5,10-
methylene-5,6,7,8-tetrahydrofolate (0.63 mm final concentration)
in a total volume of55 jl in Tris HCG buffer. After 0, 5, 10, 15, 20
and 25 min ofincubation at 37°C, the reaction was stopped on ice.
Excess of [3H]dUMP was removed by adding 300 l of activated
charcoal (15%) containing 4% trichloroacetic acid (5 min centri-
fugation at 140000g, room temperature). Tritiated water formed
during the incubation was then quantified by liquid scintillation
(Beckman LS1800, Gagny, France). Cytosolic proteins were quan-
tified according to the bicinchoninic assay (Smith et al, 1985)
using bovine serum albumin as standard. Results were expressed
as fmol of 3H,O formed per min per mg of protein. Each experi-
ment was performed in triplicate and TS activity determinations
were at least triplicated (three independent expeiments).
Dihydropyrimidine dehydrogenase (DPD) activity
DPD activity was measured according to the method described by
Harris et al (1990). Cell suspensions (5.106 to 10.106 cells ml-')
were prepared in 35 mm sodium phosphate buffer, pH 7.5.
containing 10% glycerol. The cell suspensions were then
centrifuged (5 min, 250g) and the cell pellets were stored at
400C without impairment of DPD activity. On the day of the
assay, the cell suspension was freeze-thawed three times and
centrifuged for 30 min at 28 000 g (4°C). Supernatants were kept
on ice until assayed within 15 min. The assay consisted of incu-
bating 50 il ofthe supematant with ['4C]IFU (20 JIM final concen-
tration). Total volume was 125 g.l (in 35 m.r sodium phosphate
buffer pH 7.5 containing sodium azide). The duration of incuba-
tion was 30 min at 37°C. The reaction was stopped by addition of
125 pg ofice-cold ethanol followed by 30 min ofstorage at-200C.
The samples were centrifuged (5 min, 400g) to remove proteins
and the supematant was analysed for determnination of ['4C]5-
fluorodihydroril (FUH,), ['C]5-fluoro- -alanine (FBAL) and
['4C]5-fluoro-ureido propionate (FUPA). using high-pressure
liquid chromatography (Sommadossi et al, 1982). Detection was
performed using a radioactive flow monitor (LD 506 Berthold.
Wddbad, Germany). DPD activity was calculated by taking into
account the sum of FUH,, FBAL and FUPA peaks. DPD activity
was expressed as fmol of ['4C]IFU catabolized per min and per mg
of protein. Each sample was assayed twice. The sensitivity limit
was 2 fmol min-' mg-' protein. The variability of DPD activity
during storage, evaluated by interassay reproducibility, was lower
than 12% (n=8).
RNA solation and reversetranscrnption-polynmease
chain reacfon (RT-PCR) analysis
Isolation of total RNA was performed using TRIzol (Life
Technologies). cDNA synthesis was performed with 1 gg of total
RNA in a reaction volume of 20 containing 100 ng of random
primers, 50 mM Tris-HCI, pH 8.3, 75 mM KCG, 3 mM MgCl,,
0.5 mM deoxynucleotide triphosphate, 10 mM dithiothreitol and
200 units ofSuperScript II reverse transcriptase and incubated for
10 min at room temperature, 50 min at 42°C, followed by 15 min
at 700C. RNAase H (2.5 units) was added into each sample, incu-
bated for 20 min at 370C and then stored at -200C.
PCR reactions were performed with 0.5 or 1 gl of the cDNA
reaction mixture for p53 or TS respectively in a volume of 20 gl
containing 16 mm ammonium sulphate, 67 mM Tris-HCI, pH 8.8,
0.01% Tween 20,2 mm magnesium chloride, 0.2 mM dNTP, S gM
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Table 1 Fluorouraul sensitivity and basal enzyme actvites
TS DPD
Cell lines 5-FU IC5, Doubling time (fmol mim' mf-1 (fmol mim-' mg-'
(pii) (h) protin) protein)
CAL51 62±13a 17±0.3a 2.3+1.1V 42+6a
FADu 137±62 24+2.3 0.7±0.4 11 +1
KB 240±120 20+0.2 2.9±0.7 13±2
CAL33 314±103 21 ±1.4 0.6±0.3 25+11
CAL27 450±74 23±0.3 1.5 ±0.3 14±3
PANC3 3217 ± 329 33 ± 1.2 8.4 ± 1.8 12 +2
aMean ± s.d. of three independent experiments. bMea
independent experiments.
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Figure 1 Seven-day follow-up of TS act in async
populations. TS actvity was evaluated at 72, 120 and
and was signiicay correlated with time: FL), CAL27
CAL33, r= 1.000; (^), CAL51, r= 0.655; (A), KB, r=
r= 0.991; (0), PANC3, r= 0.949. The results represer
at least five separate experiments
TS/02m PCR products were analysed using 8.8%7 polyacryl-
amide gel eectrophoresis with ethidium bromide staining. For
p53/,2m. PCR mixtures were electrophoresed on 1% agarose gel
containing 0.1 g.g ml-' ethidium bromide. Quantifications were
performed by UV transillumination using a Gel Doc 1000 system
(Bio Rad. Ivry-sur-Seine. France). Finally. for each cDNA sample.
a relative expression ratio (RER) was calculated as fluorescence
intensity ofthe TS orp53 band/fluorescence ofthe 32m band.
Cell cycle kinetics analysis
n ± s.d. of six or nine Samples were processed using flow cytometry according to the
method reported by Marchal et al (1997). Firstly. 200 -iM BrdUrd
was added directly to the culture medium for 20 min followed by
two washes with PBS. Cell suspensions were prepared by trypsi-
nation and resupended in cold PBS and. while being vortexed. the
samples were fixed by addition of 2 ml of cold 70% ethanol for
storage at -20'C. Single nuclei suspensions were prepared by
resuspending fixed cells in 0.1 N HCI and by incubation for 15 min
in 2 N HCI. After three washes with PBS. nuclei were labelled
with 40jg ml-' anti-BrdUrd mouse monoclonal antibody in PBS
containing 0.5% normal rabbit serum. 0.5% Tween 20. After 1 h
incubation at room temperature. samples were washed with PBS.
resuspended in the PBS-serum-Tween 20 solution. stained with
20gg ml-' fluorescein isothiocyanate (FHTC)-conjugated rabbit
anti-mouse immunoglobulin serum. After 1 h incubation at room
temperature. nuclei were washed twice with PBS and 25 jig ml-I
T propidium iodide (PI) PBS solution was added. At least 50 000
events were collected in each final gated histogram.
Bivariate distributions of BrdUrd content (FITC) vs DNA
0 content (PI) were measured using an Orthocyte flow cytometer
(Ortho Diagnostic Systems. Roissy. France) equipped with a
xenon lamp and a filter block for excitation at 488 nm. FITC and
PI fluorescence intensities were respectively recorded through
6 7 8 520/530-nm bandpass and 575-nm high-pass filters. The data were
analysed using Multi2D software (Phoenix Flow Systems. San
chronous ce Diego. CA. USA).
168 h after plating Calculation of S-phase duration (SPD) values was performed
0.857, (-). FaDu, according to the method reported by Begg et al (1992).
nt the means ± s.d. of
ofeach 5'- and 3'-primers. and finally 0.5 units of Taq polymerase.
The primer sequences were as follows: TS1. 5'-GGCAGATC-
CAACACATCCTCCGCT-3' (sense); TS2. 5'-CCAGAACACA-
CGTlTTGGTTGTCAG-3' (antisense) (Takeishi et al, 1985): pS3a.
5'-TCTGTGAClTGCACGTACTC-3' (sense): pS3b. 5'-CACG-
GATCTGAAGGGTGAAA-3' (antisense) (Aguilar Santelises et
al. 1996): P,-microglobulin (p2ml 5'-ACCCCCACTGAAAA-
AGATGA-3' (sense); and P2m2 5'-ATCT-lCAAACCTCCATG-
ATG-3' (antisense) (Guscow et al. 1987).
Tubes were incubated for TS vs 12m amplification for 5 min at
95'C. 1 min at 55'C and 1 min at 72'C using PHC-3 thermocycler
(Techne Cambridge. UK). The following 31 PCR cycles were
1 min at 94'C. 1 min at 55'C and 1 min at 72'C. For p53 vs P2m
amplification. samples were incubated as follows: 5 min at 95'C.
1 min at 57'C and 1 min at 72'C for one cycle and the following
33 cycles were 1 min at 94'C. 1 min at 57'C and 1 min at 72'C. In
each case, aftercompletion ofPCR cycles. the mixture was finally
incubated for 7 min at 72'C.
Statistical analysis
Unless otherwise indicated. all data are mean values ± s.d. calcu-
lated from at least three independent expenrments. Speannan's
rank correlation was used to test the correlation between the
different parameters.
RESULTS
5-FU sensitivity, TS and DPD activities (Table 1)
Table 1 shows 5-FU sensitivity and enzyme activities for the whole
cell line panel. Enzyme activities were measured before or during
exponential growing phases respectively for TS and DPD. Enzyme
activities were measurable in all cell lines and varied within a 12-
and 5-fold range for TS and DPD respectively. Cell lines displayed
marked differences in 5-FU sensitivity, with IC 0 values ranging
from 62 (CAL51) to 3217 jiM (PANC3). Cell doubling times
ranged from 18 (CAL51) to 33h (PANC3). with cells seeded at
equivalent density (10' cells ml-'). Doubling times (DT) and 5-FU
ICS. were statistically correlated (r = 0.786. P = 0.008). These
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Figure 2 Seven-day follow-up of TS gene expression evaluated at 72, 120
and 168 h after plabng was significantly correlated with time: (f), CAL27,
r= 0.987; (*), CAL33, r= 0.997; ( ), CAL51, r= 0.976; (A), KB, r= 0.986;
(A), FaDu, r= 0.993; (0), PANC3, r= 0.999. The results represent the
means ± s.d. of three separate expenments
Table 2 Cornparson of p53 and TS expression
Cell lines RER (p53/2 m) RER (TS/32 m)
CAL51 2.54 ± 0.16a 34.0 ± 2.4
FaDu 1.58 ± 0.27 8.2 ± 0.7
KB 1.51 ± 0.13 10.0 ± 0.6
CAL33 1.71 ± 0.05 15.7± 0.5
CAL27 1.64 ± 0.62 9.2 ± 0.6
PANC3 0.06+ 0.02 10.3 ± 1.0
4Aean ± s.d. of three independent experiments. RER, relative expression
ratio.
experiments clearly showed that cells with high 5-FU sensitivity
displayed shorter DT and. conversely, cells with low sensitivity
displayed the longer DT. This parallel evolution of5-FU sensitivity
with DT in these six cancer cell lines led us to investigate the rela-
tionship between cell proliferation parameters and 5-FU cytotoxi-
city. Moreover, no significant correlation was observed between TS
or DPD activities and 5-FU sensitivity in any of the six cell lines
whenever the cells were taken before, during and after their
exponential growing phase.
Enzyme activities and genes expression
TS activity and gene expression were evaluated 72, 120 and 168 h
afterplating and were significantly correlated with time (Figures 1
and 2). For nearly all cell lines, TS catalytic activity reached a
maximum at 72 or 120 h after plating (Figure 3). Maximum TS
gene expression was reached at 72 h in each case and then
deceased regularly from day 3 to day 7 (Figure 2). For all cell
lines, these maxima appeared simultaneously with the highest
S-phase fraction (Figure 3). Suprisingly. the CAL51 cell line
displayed the highest TS expression (34.0 ± 2.4. Table 2) but a
relatively low activity (3.5 ± 0.2 fmol min-' mgo- TS). Conversely.
the PANC3 cell line, which showed the highest TS activity
(7.4 ± 0.3 fmol mM mg'), presented a low TS expression
(10.3 ± 1.0).
p53 expression ranged from 0.06 (PANC3) to 2.58 (CAL51) in
5-FU-free cultured cells (Table 2). The CAL51 cell line displayed
the highestTS expression (34.0± 2.4, Table 3) and also the highest
p53 expression (2.54 ± 0.16. Table 2).
Dihydropyrimidine dehydrogenase activity
DPD catalytic activity was measured in exponentially growing
cells (day 5). Results are presented in Table 1 and show a higher
DPD activity for the CAL51 cell line (42 ±6 fmol min-' mg-'). No
significant specific correlation was observed between DPD and TS
catalytic activity or between DPD activity and 5-HU sensitivity.
Cell cycle analysis
Using flow cytometry. no difference was observed between S-
phase fractions determined with PI or BrdUrd incorporation (data
not shown).
Changes in TS activities and gene expression were associated
with variations in the distribution of cells in the cell cycle (Figure
3). Figure 3 shows that the S-phase fraction was maximum at 72 h
for CAL33. FaDu and PANC3 cell lines and at 120 h for CAL27.
CAL51 and KB cell lines. S-phase fraction was minimal when
cells reached confluence (168 h). 14% to 40% for FaDu and
CAL51 respectively. TS activity was higher in proliferating cells
(72 or 120 h) than in non-proliferating cells (Figure 3).
Nevertheless. TS activity was not significantly higher in rapidly
growing cell lines with short doubling time (Table 1).
5-FU sensitivity and proliferation
Asynchronous cells were analysed by double labelling flow
cytometry for BrdUrd and DNA content at various time points.
BrdUrd was measured as FITC fluorescence intensity (Table 2)
and DNA content as propidium iodide fluorescence intensity. The
results of labelling index (LI) and S-phase duration (SPD)
obtained forthe six cell lines were correlated with 5-FU sensitivity
(Tables 3 and 4). The evolution of5-FU sensitivity showed statis-
tically significant correlations with the LI corresponding values;
P = 0.0007, 0.0053 and 0.0665 respectively for cells taken before
(72 h). during (120 h) and after cells' exponential growth phase
(168 h. Table 4). When determined in parallel with TS activity and
gene expression, no significant correlation was found between LI
and/or SPD and TS activity or gene expression.
DISCUSSION
Previous studies (Conrad. 1971) demonstrated a relationship
between S-phase and TS protein levels and suggested that TS
would be an S-phase specific enzyme. According to our results.
TS activity was associated with variations in the distribution of
cells throughout the cell cycle and was found to be higher in proli-
ferating cells (Figure 3). However, no statistically significant
correlation was observed.
Many explanations could be considered. An evaluation of TS
activity performned in intact cells by tritium release assay could
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lead to a closer correlation between the activity of this S-phase
specific enzyme and cell cycle variation (Matherly et al, 1989).
This point was interpreted in terms of stuctural interactions
between proteins within a multienzyme complex, which was
called replitase and which was hypothesized as being responsible
for DNA replication (Plucinski et al, 1990).
If regulation mechanisms are considered, a lack of association
between cell cycle and TS activity could have several explanations
(Cadman and Heimer, 1986). In keeping with its central role in
cell growth, the TS activity is under tight control in the cell and
regulated at multiple levels. For all six cell lines, TS gene
expression decreases only within a narrow range as expressed by
the following equation y = -1.848 (±1.506)x + 19.91 (±13.88)
(Figure 1). When considering the decrease in gene expression
through cell proliferation, the ratio of TS expression between 120
and 168 h varied approximately 1.3±0.09. Our data are consistent
with those ofAli Imam et al (1987), who demonstua that ampli-
fication ofthe TS gene does not alter its tempoal expression and,
moreover, clearly showed that the TS gene is not responsible for
overproduction of TS enzyme and for consequent resistance to
5-FU (Table 1). In the PANC3 cell line, experiments showed that
high TS activity can be associated with low TS expression, also
indicating a post-translational control (Chu et al, 1990).
Overproduction ofTS arising from a corresponding increase in
TS mRNA and in the number ofcopies ofthe TS gene (Jenh et al,
1985) has been observed with a variety ofcherotherapeutic drugs
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Table 3 Cel cycle paameters (BrdJrd incorpabon) before
(72 h) during (120 h) and after (168 h) the exponential growth phase
Label e (%) S-phm dution%)
Cel lees Tune (h) Tmne (h)
72 120 168 72 120 168
CAL51 54±3a 50±5 37±5 17±4 14±0 10±1
FADu 50 ±5 54 ±2 40 ±4 14 ±3 15 ±2 12 ± 1
KB 39±1 41 ±5 35±3 9±0 10±0 9±2
CAL33 41 ±4 46 ±9 21 ±8 9±1 9±1 7±1
CAL27 37 ±4 38 ±3 21 ±5 7 0 9± 2 6±1
PANC3 32 ± 6 34 ±5 30±5 9±2 11 ±1 9±1
aMean ± s.d. of three independentexperiments.
Tabl 4 Non parametric Spearman's rank test alysis of the correlaton
(P-values) between 5+FU sesitvity and cel cycle parameters; label1g
index (U) and S-phase duration (SPD) analysed before (72 h) during (120 h)
and after (168 h) the exponential growth phase
W m (h) U SPO
72 0.0007 0.0033
120 0.0053 0.0701
168 0.0665 0.0604
Al times togeher <0.0001 <0.0001
(Schimke, 1984). In addition, acute exposure of cells to TS
inhibitors such as fluorinated pyrimidines or folate analogues also
leads to a rapid increase in T'S enzyme levels, and the biochemical
basis forthis rapid increase isunlikely to be caused by gene ampli-
fication (Chu et al, 1991a). In our case, none of the cell lines had
ever been exposed to 5-RF, and thus exhibited different sponta-
neous sensitivities and no correlation between TS gene expression
and activity was found. Nevertheless, other mechanisms could be
responsible for an increase in translation that definitely involve an
enhanced efficiency of initiation of protein synthesis. Chu et al
(1991b) evidenced a novel mechanism by which this translational
regulation may occur. They foundthatthetranslation ofhuman TS
mRNA in vitro can be inhibited by the addition ofpure human T'S
enzyme. The inhibitory effect was prevented if T'S subsrates
(dUMP or 5,10-methylene-tetrahydrofolate) or inhibitors
(FdUMP) were added to the extracts. This could confirm that the
rate of initiation of translation of human TS mRNA is very low
relative to that of other mRNAs (Kaneda et al, 1987). Assuming
that the elongation rate is normal, this would lead to a small
numberofribosomes perTS mRNA and arelatively large fraction
ofTS mRNA that is not associated with ribosomes (Kaneda et al,
1987). These observations raised the hypothesis that human TS
enzyme regulates the translation ofits own mRNA.
In CAL51 line, arelatively lowTS activity (2.3 fmol min-' mg-'
protein) can be associated with a high TS expression (34.0 ± 2.4).
TS and p53 are two proteins critically involved in DNA biosyn-
thesis, cellular growth and proliferation. As the expression ofeach
ofthese proteins is controlled, in part by atranslational regulatory
process, Chu and Allegra (1996) determined whether the expres-
sion of p53 could be regulated by T'S using an immunoprecipita-
tion RT-PCR method. Their experiments demonstrated that
binding of 1'S to p53 mRNA results in translational repression.
Although the actual mechanism by which TS represses p53
mRNA translation remains to be characterized, these preliminary
studies suggest that TS specially inhibits translational initiation.
According to p53 gene expression results (Table 2), the cell line
displaying the highest TS gene expression (CAL51) also showed
the highest p53 gene expression (Table 2), but a low TS activity
(Table 1). The excess ofp53 expression may then be able to bind
to and to sequester free TS protein, and, consequently, may inhibit
both catalytic activity and RNA binding functions (Chu and
Allegra, 1996). In order to assess the binding between TS protein
and p53 mRNA, these observations should be confimed by gel-
shift experiments.
No correlation between 5-FU sensitivity and TS gene expression
oractivity wasevidenced, which clearly shows that these two para-
meters cannot predict sensitivity or resistance to 5-FU (Table 1).
Several cellular and molecular factors related to metabolism and
disposition of 5-FU lead to alterations in tumour tissue sensitivity
(Barberi Heyob et al, 1995; Fety et al, 1997). 5-FU transport defi-
ciency has not been reported to be associated with resistance, but
aberrations in its metabolism to FdUMP (the inhibitor ofTS) or to
FUTP(the metabolite forRNAincorporation) have been associated
with resistance (Peters and VanGroeningen, 1991). In a panel of 19
cell lines from various histological origins, Beck et al (1994)
reportedthat 5-FU sensitivity andTS activity were relateddespite a
poor significance (r2 = 0.22). Like Peters et al (1994), we did not
observe any significant relationship, suggesting that sensitivity was
mainly related to a balance in the activities of anabolic and cata-
bolic enzymes, as already proposed in other studies (Evans et al,
1980, Fmdlay et al, 1997). According to our results (Table 1) this
point cannot explain the poor relationship observed between 5-FU
sensitivity and TS activity or expression as DPD activity was also
determined (Table 1). Moreover, we did notobserve any significant
relationship (P = 0.49) between TS and DPD activity. These data
suggest that additional factors may play a role in 5-FU sensitivity,
although TS and/orTK seem to be mainly implicate
Ontheotherhand, ourresults showthat S-phaseduration andcell
proliferaton (BrdUrd incorporation) could be informative for 5-FU
cytotoxicity (Table 4). At present, the best predictive factor for
cellular cytotoxicity seems to be the cell proliferation based on in
vitro BrdUrd infusion and analysis of cell labelling index (LI) by
flow cytometry. Tberefore, flow cytometry analysis could be espe-
cially informative indetermining the doubling time of umourtissue
and would therefore allow a logical choice for either a biochemical
modulation thrapy or a conconitant radio-chenmoherapy. In addi-
tion, as LI can also be used forradiotapy tratment planning by
evaluation ofcell labelling by flowcytometiy (Riccardi et al, 1988;
Marchal et al, 1997) this parameter should be especially relevant in
case ofconcomitantradio-chemotrapy.
ACKNOWLEDGEMENTS
This work was performed within the framework of the P6le
Europ6en de Sante and was supported by the French Ligue
Nationale contre le Cancer, the 'Region Lorraine' and the
'Communaute Urbaine du Grand Nancy'.
REFEFENCS
Aguilar Santelises M. Rouenbr ME Lewin N. Mellsedt H and Jondal M (1996)
Bcl-21 Bax and p53 exps in BCLL in relaion to in vi suial and
clincl progressint JaCancer0: 114-i19
O CancerResearch Canpaign 1998 Bitish Jumal ofCancer(1998) 78(1), 62-6868 J-FMirjoletetal
Ali Imam AM Crossley P1. Jackman AL and Little PFR (1987) Analysis of
thymidylate syndtase gene amplifica and mRNA levels in the cell cycle.
JBiol Chem 262: 7368-7373
Barberi Heyob M, Griffon G. Merlin JL and Weber B (1993) Sequence-depedent
gowth-inhibioy effects ofthe in vitro combinati offluo aiL cisplatin,
and dipyridamole. CancerChemotierPharmacol 33: 163-170
Barberi Heyob M, Weber B, Merli JL, Dittrich C, de Bnnjn EA,Lupoi E and
Guillemin F (1995) Evaluaion ofplasma 5-fluorouacil nucleoside levels in
patients with mnetastatic breast cancer relaionships with toxicie Cancer
Cneuother Pharmacol 37: 110-116
Beck A. Etienne MC. Cheradame S. Fischel JL, Formento P. Renee N and Milano G
(1994) A role fordihydropyrimidine dehydrogenase andthymidylate syndte
in tumoursensitivity to fluorouacil (see comnents). EurJCancer3b:
1517-1522
Begg AC, Hofland L Van Gbeke M Bartelink JC and Horiot iC (1992) Predictve
value ofpotential doubling time forradioheapy ofhead and neck tumor
patents: resuts from the EORTC cooperative trial 22851. Semun Radia Oncol
2: 22-25
Cadman E and Heimer R (1986) Levels ofthymidylate synthase dwring normal
cue growth ofL1210cells- Cancer Res 46: 1195-1198
Chou TC andTalalay P(1987) Application ofthe median-effect principle forthe
assessment oflow dose risk ofcarinogens and forthe quantiwion of
synergism and antagonism ofc c agents. In NewAvenues in
Devekopmenal CancerChemokherapv, VoL 37, Harap KR and Connors TA
(eds). pp. 37-64. Academic Press: New YorL
Chu E and AlegraCl (1996) The role ofthymidylate synthase in cellularregulation.
AdvEnzymeRegl36: 143-163
Chu E, Lai GM. Zinn S andAlBegra CJ (1990) Resistance ofa human ovaian cancer
line to 5-fluouracil associated with decreased levels of5-fluorouracil in
DNA MolPharnwol38: 410-417
Chu E. KoellerDM, Casey JL Drake JC, Chabner BA, Elwood PC. Z,nn S and
Alkegra CJ (1991a) Autoregulation ofhuman thymidylate synthse nessenger
RNA tralation by thymidylate synthase. Proc NatlAcadSci USA 88:
8977-8981
Chu F. Drake JC, Koetler DM, Zinn S, Jamis DowCA, Yeh GC and AllegraCi
(1991b) Induction ofthymidylate synase associated with Iutidrug resisance
in human breast and colon cancercell lines. Mol Pharmacol39: 136-143
Conrad AH (1971) Thymidylate syntae activity in cultured mammalian cells.
JBio Chem 39: 1318-1323
Evans RM. Iaskin JD and Hakala MT (1980) Assesnent ofgrowth-limiting events
caused by 5-fluorouacil in mouse cells andhuman cells. CancerRes4*:
4113-4122
Fety R, Rolland F, Campion L Pernocheau G, Merlin JL Barberi-Heyob M. Conroy
T. Hardouin A, Riviere A and MilanoG (1997) A l randomized tral
of5-fluorouracil (FU) dose adaptation (DA) based on pharmacokintics (PK);
clinical and economic impacts. ProcAm Soc C7ii Oncol 16: 225a
Fmdlay MPN, Cunningham D, norgan G, Clion S, Hardcaste A andAheme GW
(1997) Lack ofcorrelatio between thymidylate synase levels in pimary
coboetal tumours and subsequent response tochemothrapy. BrJCancer75:
903-909
Gussow D. Rein R, Ginjaar I, Hchstenbah F. Seemanm G. Kotman A and Ploegh
H (1987) The humanP,-microglobulin gene: primary struct anddefinition
ofthe tanscipional unit. Jlnmuno L3: 3132-3138
Haris BE, Song R, Soong SJ and Diasio RB (1990)Relatonship between
dihydropyrimidine dehydrogenase activity and plasma 5-fluorouacil levels
with evidence forcicadian variatio ifenzyme activity and plasmadrug levels
in cancerpatients receiving 5-fluooucil by proracted continuous infusion.
Cancer Res 5: 197-201
Jenh Cit Rao LG and Johnson LF (1985) Regulation ofthymidylate synthase
enzyme syndbsis in 5-fluorodeoxyuridine-resistant mouse fibroblasts during
the tansito from the resting to growing state. J Cell Phsiol 122: 149-154
Kaneda S, Takeishi K, Ayusawa D, Shimizu K, Seno T and Ahman S (1987) Role in
translatin ofthe tipletandemly repeated sequence in the 5Y-untranslated
region ofthe hluman thymidylate syndtse mRNA. Nucleic Acids Res 15:
1259-1270
Machal S. Machal C. Pache RM, BenjaafarN, OddaM. Leclerc A, Mrlin IL
Gueddani BE and Bey P(1997) Combined flow cyuometry and
analyses for the ofnasophyngeal
carcinoma cell kinetics by in vivo BrdUrd infiusi Cy-omerr 29- 165-172
Mathry Iit Schtz JD, Westin E and Goldman ID (1989) A method forthe
synchronisation ofcultred cells with aphidicolin: applcato ofL1210cells
and the study ofthe cell cycle regulatio ofthymidylate synthse and
dihydrofolate reductase. Anal Biorhem 182: 338-345
Miolet JF, Barberi-Heyob K Machal S. Cooetti P and Merlin JL (1997) In
human cancercell lines, thymidylate synthse expresson and activity are
pncipally associated with cells cycle variaton ProcAmAssoc CancerRes
38: 476
Pestalozzi BC, McGinnCJ, Kinsella Ti, Drake JC, Glemnon MC. AllegraCJ and
Johnston PG (1995) Increased thymidylate syndtase proein levels are
princially associated with proliferation but notcell cycle phase in
asynchronous human cancercells. BrJCancer71: 1151-1157
Petes GC and VanGroeningen CJ (1991) Clnical relevance ofbiochemical
mxkzlation of5-fhlorouraciL Ann Oncol2: 469-480
Peters GJ, Van DerWilt CL and VanGoenigen CJ (1994) Predictive value of
thymidylase syndtse anddihydropyrimidine dehydrogenase. EurJCancer
3SA: 1408-1411
Plucinski TM, Fager RS and Reddy GP(1990) Alboster interacon ofcomponents
ofthe replitase complex is responsible forenzyme cross-inhibiton. Mol
Phanracol : 114-120
Riccardi A. Danova M, Wilson G. Ucci G, D6rmerP, Mazzini G. Brgnatelli S.
Girimo b, McNaly NJ and Ascari E (1988) Cell kinetics in human
malignanies studies with in vivo mnisution ofbromodeoxyuri and
flowcytomey. CancerRes 48: 6238-6245
S mke RT (1984) Gene fi drug resistance, and cancer. CancerRes 44:
1735-1742
Smith PK, Krohn RI, Hermanson GT. Mallia AK. GarterFH, Provenzano MD.
Fupmoto EK, Goeke NM, Olson Bi and Klenk DC (1985) Measrement of
prtein using binhoninic acid AnalBiochem 15 76-85
9ommaossi JP, Gewirtz DA. Diasio RB, Aubert C. Cano JP andGoldman ID
(1982) Rapid catabolism of5-fluorouracil in freshly isolated rat hepatocytes as
analyzed by high-perfomance liquidchrmaography. JBiol Chem 4:
2858-2864
Sto RKm Ord RW, Greenwood MT, Mirdamadi B, Chu FK and Belfort M (1984)
Cell cycle dependent expression ofdtymidylatesynthase in Saccharomvces
cerevsiuae. Mot CellBid 4: 2858-2864
Takeishi K, Kaneda S, Ayusawa D, Shimizu K, Gotob 0 and Seno T(1985)
Nucleotide sequence ofafunctional cDNA forhuman thymidylate syndhse.
NuclicAcids Res 13: 2035-2043
Britsh Joural ofCancer(1998) 78(1), 62-68 0 CancerResearchCampaign 1998